Recent Headlines
Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Size Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 30, 2016 - DelveInsight
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
AXSource Global Launches an Enhanced ERP Solution for Life Sciences Companies
AXOQCS™ is complete business solution developed for Microsoft Dynamics AX that provides quality and compliance functionality. Pharmaceutical and Medical Devices manufacturers need a solution that is flexible, responsive, and integrated. AXOQCS™ is a unique ERP solution for Pharma and Life Sciences manufacturers that streamlines and integrates quality and compliance processes, helping them comply with FDA Good Manufacturing Practices while maintaining efficiency and profitability across business. - March 26, 2016 - AxSource
Hematogenix Laboratory Services, LLC Announces the Availability of FDA Approved PD-L1 Companion Diagnostic Tests
Hematogenix Laboratory Services Announces the Availability of PD-L1 Companion Diagnostic Tests for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression on or after Platinum-Containing Chemotherapy as well as a PD-L1 Complementary Diagnostic Test to Support Bristol-Myers Squibb's OPDIVO® Anti-PD-1 Therapy for Non-Squamous Non-Small Cell Lung Cancer. - March 24, 2016 - Hematogenix
New York Start-Up Launches Healthy, Clean Nutrition Bar
New Nutrition Bar Shuns Added Sugars, Sweeteners, GMOs; Says Good-Bye to Gluten - March 24, 2016 - Golda Bar
The Gut Health Protocol - Natural Solutions for Nagging Gut Issues, All Backed by Scientific Research
Are you plagued by stomach and intestinal issues, acid reflux, diarrhea, constipation, brain fog? Have you been to several doctors and haven’t seen any long term relief? This was author John Herron a few years ago. Herron decided to research the medical studies himself. What he found was stunning, there are solutions out there, but because they’re natural doctors don’t prescribe them. Now all of this is in the book, “The Gut Health Protocol.” - March 24, 2016 - The Gut Health Protocol
New Bioreactor Tubing Kits from AdvantaPure(R) Speed Turnaround and Increase Processing Capacity; Single-Use and Customizable for Benchtop Bioreactors
Custom, Single-Use Bioreactor Tubing Kits, new from AdvantaPure, contain tubing, filters and connectors for harvest, vent, sparge and addition lines used in benchtop bioreactors. Because the kits arrive preassembled, they provide quicker turnaround time, convenience and less chance of cross contamination. Platinum-cured silicone or AdvantaFlex(R) TPE tubing may be selected as the tubing components in each kit. This product will be exhibited at Interphex booth 3055. - March 24, 2016 - AdvantaPure
Low T St. Louis Opens St. Peters' Location
Local testosterone medical practice to open 11 additional diagnostic lab locations. - March 20, 2016 - Low T St. Louis
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 19, 2016 - DelveInsight
Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast- 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 18, 2016 - DelveInsight
Respiratory Syncytial Virus (RSV) Infections-Market Insights, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 17, 2016 - DelveInsight
Multiple Myeloma - Market Insights, Epidemiology and Market Forecast- 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 16, 2016 - DelveInsight
Source-Omega Grows as DHA Private Labeler of Registered Ingredient SOURCE OIL® from Chromista
Source-Omega announces many new 3rd party DHA omega-3 supplement private labels approved to launch in the first half of 2016. Several of the new DHA products seek to benefit prenatal, pregnant and nursing markets in the USA, China and Singapore. SOURCE OIL® is a water extracted DHA algae oil... - March 14, 2016 - Source-Omega
Tabula Rasa HealthCare CIO Receives 2016 Executive Management Award
Tabula Rasa HealthCare CIO Joseph J. Filippoli was honored by SmartCEO Magazine with the 2016 Executive Management Award at a gala celebration March 8. The award recognizes the "leadership and accomplishments of Philadelphia's management all-stars. Winners are recognized for their creative management vision, leadership philosophy, innovative strategy and undeniable work ethic." - March 11, 2016 - Tabula Rasa HealthCare
A Tale of Two New Hepatitis C Drugs
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
April 5, 2016 Webinar to Offer Organizational Readiness Assessment for Next Generation ACO Participation
Two thought leaders in value-based reimbursement strategy will outline a roadmap to readiness for CMS's Next Generation ACO and other risk-based payment models during an April 5, 2016 webinar sponsored by the Healthcare Intelligence Network. - March 11, 2016 - Healthcare Intelligence Network
AdvantaPure(R) Introduces BioClosure(R) System Assemblies That Reduce Assembly Time, Protect Product Integrity and Decrease Contamination Risks
Single-Use components supplier AdvantaPure announces the availability of BioClosure System Assemblies. The ready-to-use, closed container systems are designed to save customers time and expense in their bioprocess applications by eliminating cleaning validations, reducing the need for multiple inventoried parts, and assembling onsite. The Single-Use assemblies also help decrease contamination risks. Applications include aseptic sampling, cell growth, filling, process R&D and cold storage. - March 10, 2016 - AdvantaPure
Population Health Management Needs Fueling Data Analytics Frenzy, Survey Finds
A passion to improve population health is the top driver behind healthcare's dive into data analytics, according to 2016 Data Analytics and Integration metrics from the Healthcare Intelligence Network (HIN). - March 09, 2016 - Healthcare Intelligence Network
Makers Nutrition Launches Premium Stock Formulas
Fast-Growing Nutraceutical Company Offers Nine Popular Stock Formulas to Vitamin and Supplement Businesses - March 08, 2016 - Makers Nutrition, LLC
Stem Cell Oncology – Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Stem Cell Oncology –Pipeline Insights, 2016 to its portfolio. With this launch, DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this, DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. - March 08, 2016 - DelveInsight
Friends Salon N Spa Offers Phyto Sintesi Lifting Serum at a Discount on Online Purchase
Experience beautiful, tighter skin by using the innovative Phyto Sintesi Lifting Serum comprising several natural active ingredients. Overcome the signs of premature aging with the power of vegetal extracts, caffeine and vitamins. The serum is offered at a discount now. - March 04, 2016 - Friends Salon N Spa
March 31, 2016 Webinar: U.S.'s Largest Commercial Episodes of Care Payor on Payor-Provider Partnership That Improved Clinical Outcomes & Reduced Total Cost of Care
Horizon Blue Cross Blue Shield New Jersey (BCBSNJ) will outline the value-based payor-provider partnership that yielded $3 million in shared savings in 2014 for 51 participating specialty practices during a March 31, 2016 webinar sponsored by the Healthcare Intelligence Network. - March 03, 2016 - Healthcare Intelligence Network
Indication-Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 03, 2016 - DelveInsight
Silver Wolf Nutrition Launches Effective New Protein Powder Made from Peas
Silver Wolf Nutrition has launched a new type of protein powder made exclusively from peas. The product offers 30 grams of protein in a relatively small amount of powder, giving people a vegan, cost-effective, and hypoallergenic solution to their diet and muscle building needs. - March 02, 2016 - Silver Wolf Nutrition
Ixogel®: Agreement on Special Protocol Assessment (SPA) by the US Food and Drug Administration for the Prevention of Lyme Disease
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the company has reached agreement with the US Food and Drug Administration (FDA) on the phase III protocol according to the Special Protocol... - March 01, 2016 - Ixodes AG
March 29, 2016 Webinar Will Measure and Evaluate the Impact of Home Visits for Clinically Complex Patients
Community Care of North Carolina will describe the framework and impact of its technology-driven post-discharge home visit intervention for clinically complex Medicaid patients during a March 29, 2016 webinar sponsored by the Healthcare Intelligence Network. - February 29, 2016 - Healthcare Intelligence Network
Speaking of NEC Podcast Retrospective Launches February 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 27, 2016 - The Morgan Leary Vaughan Fund, Inc.
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 26, 2016 - DelveInsight
The Addictions Academy Offers Free Training to Drug Torn Liberty City
The Addictions Academy and Cali Estes offers a free intervention training to an advocate in Liberty City to assist with the drug epidemic in an area where resources are limited. - February 26, 2016 - The Addictions Academy
Makers Nutrition Hires Stephen Finnegan as General Manager
Rapidly growing nutraceutical company turns to seasoned executive to help lead expansion. - February 25, 2016 - Makers Nutrition, LLC
Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report STAT3 inhibitors-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. - February 25, 2016 - DelveInsight
Indication-Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - February 25, 2016 - DelveInsight
Wego Health to Demonstrate the Importance of Patient Influencers During ePharma Summit 2016
Company will ask for a single question to show how the pharmaceutical industry can benefit from engaging patient community leaders. - February 24, 2016 - Wego Health
ALPCO's New NT-proBNP ELISA Offers Cost Savings and Flexibility
ALPCO recently announced the release of its new NT-proBNP (1-76) ELISA, offering researchers investigating cardiovascular disease, kidney disease, and diabetes with a flexible, user friendly and cost effective tool. The assay is highly characterized to measure changes in levels of NT-proBNP, and... - February 23, 2016 - ALPCO
AdvantaPure(R) Introduces AdvantaFlex® Sterile Molded Tubing Ends to Add Versatility to Tubing
Single-Use, molded, mini Tri-Clamp tubing ends are designed to improve production and reduce operational costs involved with biopharma processes. Made from AdvantaFlex biopharmaceutical grade TPE tubing and an overmolding process, the ends are well suited for aseptic fluid transfer applications. They reduce the potential for leaks and help simplify cleaning and validation procedures. AdvantaFlex Molded Tubing Ends are compatible with sterile tubing welders. - February 21, 2016 - AdvantaPure
PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has a strong presence in the Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight Report, PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016 has received great response and feedback from clients. - February 19, 2016 - DelveInsight
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 19, 2016 - DelveInsight
ALPCO Releases New Basophil Activation Test Validated for the Evaluation of Kinase Inhibitors in Early Drug Development
ALPCO has released its new InhibiScreen Basophil Activation Test (BAT) which was developed and validated specifically for the evaluation of kinase inhibitors during early drug development. - February 16, 2016 - ALPCO
Tabula Rasa Healthcare Pharmacy Simulation Software Tested by Schools of Pharmacy
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
Real Endpoints’ RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that’s exactly what happened. - February 12, 2016 - Real Endpoints
Studies Use Epitope Diagnostics’ ELISA Kit to Establish Chromogranin A as a Potential Prognostic Marker in Prostate Cancer Patients Treated with Antiandrogens
Italian research group uses Epitope Diagnostics' Chromogranin A ELISA kit in study to determine CgA as a potential prognostic marker in castration-resistant prostate cancer patients treated in abiraterone or enzalutamide. - February 11, 2016 - Epitope Diagnostics, Inc.
Advanced Electrophoresis Solutions Signs an Exclusive Distributor Partner for Europe
AES (Advanced Electrophoresis Solutions Ltd.), a pioneer in designing and manufacturing the most reliable, high performance, and high throughput CEInfinite whole column imaging detection capillary isoelectric focusing (iCIEF) systems, proprietary cartridges, ampholytes, and pI standards for the... - February 11, 2016 - Advanced Electrophoresis Solutions Ltd.
PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology-based Indications & Mechanism of Action (MOA). - February 10, 2016 - DelveInsight
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. - February 06, 2016 - Bioquark Inc.
Noninvasix Secures Finalist Slot in Healthcare Innovation Challenges
CEO Graham Randall to present patient monitoring device at SPIE Startup Challenge, Pediatric Device Innovation Competition. - February 03, 2016 - Noninvasix
New Company Providing Paint Services for Manufacturers Hosts Open House Showcasing Highly Automated Line in Cheney, Kansas
Albers Finishing & Solutions provides liquid paint services to regional and national customers. the liquid paint line is capable of painting 2,000 to 3,000 parts per day and features an automated conveyor that moves load bars forward and reverse or even stops them independently of the other load bars, a three-stage wash, dry off oven, two paint booths with Fanuc robots applying liquid primer and paint, a dual-lane energy-efficient cure oven and a load-assist lifter. - February 02, 2016 - Kasa Companies
Speaking of NEC Podcast Featuring Dr. Corrine Hanson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 02, 2016 - The Morgan Leary Vaughan Fund, Inc.
Coalition Forms to Study Medication Risk in Workforce Populations
Tabula Rasa HealthCare and The Greater Philadelphia Business Coalition on Health have partnered to examine the extent of medication risk in a diverse workforce population and the opportunities to mitigate that risk for the benefit of improving the health and welfare of employees and reducing unnecessary health care costs. - February 01, 2016 - Tabula Rasa HealthCare
aiaTranslations Offering Discounts to Healthcare Associations
As part of the annual patient access drive, aiaTranslations, the leader in life sciences translation services, is offering discounted translation pricing to patient advocacy and education non-profits. - January 29, 2016 - aiaTranslations LLC
Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016
DelveInsight, the leading market research and consulting company has added new report “Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016” to its portfolio. CAR-T cells are the next targeted agents in Oncology. CAR-T... - January 29, 2016 - DelveInsight